跳转至内容
Merck
CN
  • High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue.

High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue.

Cell and tissue research (2015-05-01)
Betul Kul Babur, Kathryn Futrega, William B Lott, Travis Jacob Klein, Justin Cooper-White, Michael Robert Doran
摘要

Engineered biphasic osteochondral tissues may have utility in cartilage defect repair. As bone-marrow-derived mesenchymal stem/stromal cells (MSC) have the capacity to make both bone-like and cartilage-like tissues, they are an ideal cell population for use in the manufacture of osteochondral tissues. Effective differentiation of MSC to bone-like and cartilage-like tissues requires two unique medium formulations and this presents a challenge both in achieving initial MSC differentiation and in maintaining tissue stability when the unified osteochondral tissue is subsequently cultured in a single medium formulation. In this proof-of-principle study, we used an in-house fabricated microwell platform to manufacture thousands of micropellets formed from 166 MSC each. We then characterized the development of bone-like and cartilage-like tissue formation in the micropellets maintained for 8-14 days in sequential combinations of osteogenic or chondrogenic induction medium. When bone-like or cartilage-like micropellets were induced for only 8 days, they displayed significant phenotypic changes when the osteogenic or chondrogenic induction medium, respectively, was swapped. Based on these data, we developed an extended 14-day protocol for the pre-culture of bone-like and cartilage-like micropellets in their respective induction medium. Unified osteochondral tissues were formed by layering 12,000 osteogenic micropellets and 12,000 chondrogenic micropellets into a biphasic structure and then further culture in chondrogenic induction medium. The assembled tissue was cultured for a further 8 days and characterized via histology. The micropellets had amalgamated into a continuous structure with distinctive bone-like and cartilage-like regions. This proof-of-concept study demonstrates the feasibility of micropellet assembly for the formation of osteochondral-like tissues for possible use in osteochondral defect repair.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
纯乙醇, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
地塞米松, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
L -抗坏血酸, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
氯化钙 溶液, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
纯乙醇, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
L -抗坏血酸, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
L -抗坏血酸, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-脯氨酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture
Sigma-Aldrich
L -抗坏血酸, 99%
Sigma-Aldrich
丙酮酸钠, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
L -抗坏血酸, reagent grade, crystalline
Sigma-Aldrich
氯化钙, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
Sigma-Aldrich
丙酮酸钠, ReagentPlus®, ≥99%
Sigma-Aldrich
磷酸钠 二元, ReagentPlus®, ≥99.0%
Sigma-Aldrich
亚甲蓝, certified by the BSC
Sigma-Aldrich
乙醇胺, ≥99%
Sigma-Aldrich
磷酸钠 二元, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.0%
Sigma-Aldrich
亚甲蓝 溶液, concentrate according to Ehrlich, concentrated, aqueous solution
Sigma-Aldrich
羟基磷灰石, nanopowder, <200 nm particle size (BET), ≥97%, synthetic
Sigma-Aldrich
乙醇胺, ≥98%
Sigma-Aldrich
磷酸钠 二元, BioXtra, ≥99.0%
Sigma-Aldrich
L-脯氨酸, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
磷酸钠 二元, Molecular Biology, ≥98.5% (titration)
SAFC
L-脯氨酸
Sigma-Aldrich
乙醇胺, purified by redistillation, ≥99.5%
Sigma-Aldrich
纯乙醇, 190 proof, meets USP testing specifications
Sigma-Aldrich
L -抗坏血酸, ACS reagent, ≥99%
Sigma-Aldrich
L-脯氨酸, BioUltra, ≥99.5% (NT)